Paradigm will collaborate with Bristol Myers Squibb to build a new end-to-end clinical trial operating model across design, recruitment, and data collection. Starting with oncology and expanding to other therapeutic areas, Paradigm will enable BMS to enroll patients from providers across the Paradigm Network of health systems and already use Paradigm software to reduce the burden of clinical trial recruitment and operations.  The administrative burden of running a clinical trial contributes t...